HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Claire Gallois Selected Research
Claire Gallois Research Topics
Disease
16
Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 01/2021
8
Colonic Neoplasms (Colon Cancer)
04/2024 - 10/2018
8
Neoplasms (Cancer)
03/2024 - 10/2018
5
Microsatellite Instability
03/2024 - 01/2022
4
Neoplasm Metastasis (Metastasis)
10/2022 - 03/2021
2
Disease Progression
10/2023 - 03/2020
2
Gastric Outlet Obstruction
11/2022 - 04/2021
2
Hemorrhage
06/2022 - 02/2017
2
Adenocarcinoma
01/2021 - 03/2020
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2023
1
Ileitis
10/2023
1
Colitis
10/2023
1
Cholangiocarcinoma
10/2022
1
Crohn Disease (Crohn's Disease)
06/2022
1
Intestinal Perforation
06/2022
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2022
1
Proteinuria
06/2022
1
Ulcerative Colitis
06/2022
1
Diarrhea
06/2022
1
Hypertension (High Blood Pressure)
06/2022
1
Peritoneal Neoplasms
01/2022
1
Cardiotoxicity
01/2022
1
Sarcopenia
11/2021
1
Acute Kidney Injury (Acute Renal Failure)
01/2021
1
Stomach Neoplasms (Stomach Cancer)
03/2020
1
Malnutrition (Nutritional Deficiencies)
01/2019
Drug/Important Bio-Agent (IBA)
8
Oxaliplatin (Eloxatin)
FDA Link
Generic
03/2024 - 10/2018
6
Cetuximab (Erbitux)
FDA Link
01/2023 - 10/2018
5
Immune Checkpoint Inhibitors
IBA
03/2024 - 10/2021
5
encorafenib
IBA
01/2023 - 01/2021
3
Irinotecan (Camptosar)
FDA Link
Generic
10/2023 - 01/2021
2
Sodium Glutamate (Accent)
IBA
03/2024 - 01/2023
2
Bevacizumab (Avastin)
FDA Link
06/2022 - 10/2021
2
pembrolizumab
IBA
01/2022 - 10/2021
1
Glucocorticoids
IBA
04/2024
1
Prion Proteins
IBA
04/2024
1
avelumab
IBA
10/2023
1
RNA (Ribonucleic Acid)
IBA
01/2023
1
Biomarkers (Surrogate Marker)
IBA
01/2023
1
Tumor Biomarkers (Tumor Markers)
IBA
11/2022
1
Gemcitabine
FDA Link
10/2022
1
Infliximab (Remicade)
FDA Link
06/2022
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
06/2022
1
regorafenib
IBA
01/2022
1
raltitrexed (D 1694)
IBA
01/2022
1
folfirinox
IBA
01/2022
1
trifluridine tipiracil drug combination
IBA
01/2022
1
Circulating Tumor DNA
IBA
05/2021
1
binimetinib
IBA
01/2021
1
ErbB Receptors (EGF Receptor)
IBA
01/2021
1
human ERBB2 protein
IBA
03/2020
1
Trastuzumab (Herceptin)
FDA Link
03/2020
1
Monoclonal Antibodies
IBA
03/2020
1
Anticoagulants
IBA
02/2017
Therapy/Procedure
12
Drug Therapy (Chemotherapy)
03/2024 - 01/2019
5
Adjuvant Chemotherapy
03/2024 - 10/2018
5
Therapeutics
03/2024 - 02/2017
2
Precision Medicine
04/2024 - 11/2022
1
Immunotherapy
12/2023
1
Gastroenterostomy
11/2022
1
Stents
11/2022
1
Contraindications
01/2022
1
Gastric Bypass (Roux-en-Y Gastric Bypass)
04/2021
1
Neoadjuvant Therapy
01/2021
1
Operative Surgical Procedures
02/2017